Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

B Cell Activation and Differentiation

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

Primary Lymphoid Organs

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...

Secondary Lymphoid Organs

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

5-methylcytosine and 5-hydroxymethylcytosine are synergistic biomarkers for early detection of colorectal cancer.

Communications medicine·2026

Same author

A survey of dosimetry quality assurance practice at UK small animal radiation research platform (SARRP) facilities.

Biomedical physics & engineering express·2025

Same author

Deaf children with cochlear implants in Chile: A national analysis of health determinants and outcomes in the Latin American context.

PloS one·2025

Same author

The Influence of Relative Age and Biological Maturity on Youth Weightlifting Performance.

Pediatric exercise science·2025

Same author

Comparison of Shared Class I HLA-Bound Noncanonical Neoepitopes between Normal and Neoplastic Tissues of Pancreatic Adenocarcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024

Same author

Injury and violence in the context of sustainable development: The first Bethune Round Table in Africa, Bethune Round Table 2024, Conference on Global Surgery, May 16-18, 2024, Addis Ababa, Ethiopia.

Canadian journal of surgery. Journal canadien de chirurgie·2024

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

NHL (diffuse large B-cell lymphoma).

Mark Hill¹, Fiona Kyle

¹Kent Oncology Centre, Kent, UK.

BMJ Clinical Evidence

|March 17, 2011

Summary

This systematic review evaluates first-line treatments for aggressive non-Hodgkin's lymphoma (diffuse large B-cell lymphoma). It analyzes the effectiveness and safety of various chemotherapy regimens and stem-cell support options.

Area of Science:

Oncology
Hematology
Clinical Medicine

Background:

Non-Hodgkin's lymphoma (NHL) is a common cancer in the UK with geographical incidence variations.
NHL incidence increased in the UK between 1993 and 2002, affecting males more than females.
Diffuse large B-cell lymphoma is a common subtype of aggressive NHL.

Purpose of the Study:

To systematically review the effectiveness and safety of first-line treatments for aggressive NHL.
To answer clinical questions regarding treatments for aggressive or relapsed aggressive diffuse large B-cell lymphoma.
To evaluate interventions including chemotherapy and stem-cell support.

Main Methods:

Systematic review of medical literature up to January 2010.
Inclusion of 26 systematic reviews, RCTs, and observational studies.

Related Experiment Videos

Last Updated: Jun 3, 2026

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

Inclusion of harms alerts from regulatory agencies (FDA, MHRA).

GRADE evaluation of evidence quality for interventions.

Main Results:

Identified 26 studies meeting inclusion criteria.
Evaluated the quality of evidence for various treatment interventions.
Data synthesized to assess effectiveness and safety.

Conclusions:

Presents information on the effectiveness and safety of multiple interventions for aggressive NHL.
Interventions reviewed include various chemotherapy regimens (e.g., CHOP variants, ACVBP, MACOP-B) and stem-cell support.
Provides evidence base for clinical decision-making in NHL treatment.